The results showed that the overexpression of BCL6 could upregulate E-cadherin and downregulate N-cadherin, vimentin, and MMP9, indicating that BCL6 could inhibit the EMT process of GC cells (Fig. 2F). This evidence concerns the gene CDH1 and gastric cancer.